Home LiteratureArticle Details
PMID: 1740666 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Restoration of a tumorigenic phenotype by beta 2-microglobulin transfection to EL-4 mutant cells.

The Journal of experimental medicine ·Vol. 175 ·No. 3 ·1992-03-01 ·Pages 843-6

Glas R, Sturmhöfel K, Hämmerling GJ, Kärre K, Ljunggren HG

Abstract

It has frequently been suggested that loss of beta 2-microglobulin (beta 2m) in tumor cells may lead to malignant progression due to escape from immunological recognition. Here, we directly tested the role of beta 2m expression in tumorigenicity. A beta 2 m loss mutant (C4.4-25-), selected from the murine lymphoma EL-4, showed a marked reduction in tumorigenicity as compared with EL-4 in normal C57B1/6 (B6) mice. The reduced tumorigenicity was directly related to beta 2 m expression. Transfection of an intact murine beta 2m gene markedly increased the tumorigenic potential. The reduced tumorigenicity of C4.4-25- compared with beta 2m transfected cells was observed also in athymic B6 nu/nu mice, but was abolished in B6 mice depleted of natural killer (NK) 1.1-positive cells. These results show that restoration of beta 2m expression can promote tumorigenicity and demonstrate for the first time that induction of major histocompatibility complex class I expression by transfection can lead to escape from NK cells in vivo.

MeSH Terms
Animals Cell Separation Flow Cytometry Humans Mice Mice, Nude Mutation Phenotype Transfection Tumor Cells, Cultured beta 2-Microglobulin/genetics
Chemicals
beta 2-Microglobulin
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Glas R
Department of Tumor Biology, Karolinska Institutet, Stockholm, Sweden.
Sturmhöfel K
Hämmerling G J
Kärre K
Ljunggren H G
References (15)
15 references, click to expand
  1. MHC antigen expression in colorectal tumours.
    Semin Cancer Biol. 1991 Feb;2(1):17-21 PMID: 1912514
  2. Major histocompatibility antigens: the human (HLA-A, -B, -C) and murine (H-2K, H-2D) class I molecules.
    Cell. 1981 May;24(2):287-99 PMID: 7016338
  3. Rejection of class I MHC-deficient haemopoietic cells by irradiated MHC-matched mice.
    Nature. 1991 Jan 24;349(6307):329-31 PMID: 1987491
  4. Natural resistance against lymphoma grafts conveyed by H-2Dd transgene to C57BL mice.
    J Exp Med. 1988 Oct 1;168(4):1469-74 PMID: 3171481
  5. Perspectives on the role of MHC antigens in normal and malignant cell development.
    Adv Cancer Res. 1989;53:181-245 PMID: 2678947
  6. Altered growth of a human neuroendocrine carcinoma line after transfection of a major histocompatibility complex class I gene.
    Proc Natl Acad Sci U S A. 1989 Jun;86(12):4700-4 PMID: 2660144
  7. Selective loss of beta 2-microglobulin mRNA in human colon carcinoma.
    J Exp Med. 1989 Jan 1;169(1):309-14 PMID: 2642530
  8. Prevention of allogeneic bone marrow graft rejection by H-2 transgene in donor mice.
    Science. 1989 Nov 3;246(4930):666-8 PMID: 2814488
  9. Partial suppression of anchorage-independent growth and tumorigenicity in immunodeficient mice by transfection of the H-2 class I gene H-2Ld into a human colon cancer cell line (HCT).
    Proc Natl Acad Sci U S A. 1988 Nov;85(22):8543-7 PMID: 3186742
  10. Depletion of natural killer cells in mice by monoclonal antibody to NK-1.1. Reduction in host defense against malignancy without loss of cellular or humoral immunity.
    J Immunol. 1987 Jun 15;138(12):4539-44 PMID: 3584981
  11. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy.
    Nature. 1986 Feb 20-26;319(6055):675-8 PMID: 3951539
  12. Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism.
    J Exp Med. 1985 Dec 1;162(6):1745-59 PMID: 3877776
  13. Transfection of beta 2-microglobulin restores IFN-mediated protection from natural killer cell lysis in YAC-1 lymphoma variants.
    J Immunol. 1990 Jul 1;145(1):380-6 PMID: 2113557
  14. In search of the 'missing self': MHC molecules and NK cell recognition.
    Immunol Today. 1990 Jul;11(7):237-44 PMID: 2201309
  15. Alteration of the natural killer repertoire in H-2 transgenic mice: specificity of rapid lymphoma cell clearance determined by the H-2 phenotype of the target.
    J Exp Med. 1991 Aug 1;174(2):327-34 PMID: 1856626
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1992-03-01
Pages
843-6
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2119145
Subset
IM
Grants
NCI NIH HHS · 1 R01 CA-44882-01 · United States
NCI NIH HHS · 5 R01 CA-25250-06 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]